About Elevai Labs
Elevai Labs is a private company based in Newport Beach, California, incorporated in 2020 in Delaware. It has reported $5,656,995 raised in six offerings on Form D since October 2021.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Sep 8, 2023 | Sep 22, 2023 | $249,996of $549K target | 2 | $124K | Equity, OptionsRule 506(b) | Form D ↗ |
| Mar 14, 2023 | Apr 27, 2023amended Sep 11, 2023 | $463,589of $1.6M target | 11 | $42,144 | EquityRule 506(b) | Form D/A ↗2 earlier filings |
| Mar 3, 2023 | Mar 17, 2023 | $750,000of $1.5M target | 1 | $750K | Equity, OptionsRule 506(b) | Form D ↗ |
| Jul 15, 2022 | Jul 28, 2022amended Nov 1, 2022 | $2,963,834of $4.2M target | 44 | $67,360 | Equity, Debt, Securities on exerciseRule 506(b) | Form D/A ↗1 earlier filing |
| Aug 24, 2021 | Oct 1, 2021amended Dec 10, 2021 | $1,090,577of $2.0M target | 13 | $83,891 | EquityRule 506(b) | Form D/A ↗2 earlier filings |
| Jun 24, 2020 | Oct 1, 2021 | $138,999fully sold | 7 | $19,857 | Equity, Debt, Securities on exerciseRule 506(b) | Form D ↗ |
| Total, six offerings | $5,656,995 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Elevai Labs's Form D filed Sep 22, 2023.
BL
Braeden Lichti
Promoter
First appears on the Form D that Elevai Labs filed on October 1, 2021; on 9 of its 11 filings.
Braeden Lichti appears on 14 Form D filings at 3 companies. Show all
- Elevai Labs, promoter: Oct 1, 2021 (2 filings) · Oct 14, 2021 (amended) · Dec 10, 2021 (amended) · Jul 28, 2022 · Nov 1, 2022 (amended) · May 31, 2023 (amended) · Sep 11, 2023 (amended) · Sep 22, 2023
- Qualigen Therapeutics, director: Nov 22, 2024 · Aug 13, 2025
- Aquabounty Technologies, director: Nov 4, 2025 · Apr 15, 2026 · Jul 1, 2026
CM
Crystal Muilenburg
Director
First appears on the amended Form D that Elevai Labs filed on September 11, 2023; on 2 of its 11 filings.
JD
Julie Daley
Director
First appears on the amended Form D that Elevai Labs filed on September 11, 2023; on 2 of its 11 filings.
CK
Chris Kraneiss
Executive officer
First appears on the Form D that Elevai Labs filed on March 17, 2023; on 5 of its 11 filings.
JP
Jeffrey Parry
Director
First appears on the amended Form D that Elevai Labs filed on September 11, 2023; on 2 of its 11 filings.
Jeffrey Parry appears on 4 Form D filings at 2 companies:
- Globus Maritime, director: Jul 1, 2020 · Jul 23, 2020
- Elevai Labs, director: Sep 11, 2023 (amended) · Sep 22, 2023
HS
Hatem (Tim) Abou-Sayed
Executive officer and director
First appears on the Form D that Elevai Labs filed on October 1, 2021; on 9 of its 11 filings.
BB
Brenda Buechler
Executive officer
First appears on the Form D that Elevai Labs filed on March 17, 2023; on 5 of its 11 filings.
GB
Graydon Bensler
Chief Financial Officer and director
On every Form D that Elevai Labs has filed: 11 filings, from Oct 1, 2021 to Sep 22, 2023.
Graydon Bensler appears on 15 Form D filings at 3 companies. Show all
- Elevai Labs, chief financial officer and director: Oct 1, 2021 (2 filings) · Oct 14, 2021 (amended) · Dec 10, 2021 (amended) · Jul 28, 2022 · Nov 1, 2022 (amended) · Mar 17, 2023 · Apr 27, 2023 · May 31, 2023 (amended) · Sep 11, 2023 (amended) · Sep 22, 2023
- Qualigen Therapeutics, director: Nov 22, 2024
- Aquabounty Technologies, director: Nov 4, 2025 · Apr 15, 2026 · Jul 1, 2026
JP
Jordan Plews
Executive officer and director
On every Form D that Elevai Labs has filed: 11 filings, from Oct 1, 2021 to Sep 22, 2023.
Earlier filings also listed
- Yi Guo · directorLast listed on the amended Form D that Elevai Labs filed on December 10, 2021; on 4 of its 11 filings.